The major players in the rheumatoid arthritis diagnostic tests market include Abbott Diagnostics (Abbott Laboratories), Antibodies Inc., Beckman Coulter, Inc., Euro Diagnostica AB, F. Hoffmann-La Roche Ltd., Qiagen NV, Siemens Healthcare GmbH, Thermo Fisher Scientific Inc.
The high rate of people affected by autoimmune disorders like RA is the principal facilitator for the RA diagnostic tests market’s growth. The high prevalence of RA among the growing geriatric population will further propel the market growth. Government and private insurance companies providing reimbursement for the treatment of RA will be a market booster. Continued R & D of biomarker-based diagnostic tests and commercialization of reliable, cost-effective test kits will create lucrative opportunities for this market’s growth. The availability of a broad range of test kits to diagnose the inflammation will support market growth. The major roadblock affecting this market is the limited sensitivity and concreteness of the test kits in diagnosis.
By Test Type
- Serology Test
- Erythrocyte Sedimentation Rate (ESR)
- Rheumatoid Factor (RF)
- Anti-cyclic Citrullinated Peptide (anti-CCP)
- Antinuclear Antibody (ANA)
- Uric Acid
- Other Tests
- Monitoring RA Treatment Efficiency Tests
- Salicylate Level Count
- Muscle Enzyme Tests (CPK, Aldolase)
- Creatinine Test
By End User
- Diagnostic Laboratories
- Private Laboratories
- Public Laboratories
- Ambulatory Surgical Centers
Demand for rheumatoid arthritis diagnostic tests market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa.
Source: https://www.valuemarketresearch.com/report/rheumatoid-arthritis-diagnostic-tests-market
Naira Shekhawat has been into Content Writing just after completing her Graduation in English Literature. Her love for words has won her many accolades in her respective jobs ever since. Naira covers business sections for VMR News. She is a traveller by heart and loves writing on food blogs as a freelancer.